The need to develop a framework for human-relevant research in India: Towards better disease models and drug discovery

The low translational effectivity of animal fashions to people, and the event of new-age methodologies which are human-cell based mostly, is fuelling a paradigm change throughout the globe. On this views paper, we talk about the present state of analysis, funding, and regulation in these 21st century applied sciences, together with organoids and organ-on-chip in India. Not too long ago, a road-map was drawn by Indian Council for Medical Analysis (ICMR) relating to options to animals in analysis in India and it additionally held a particular session in January 2018 to debate newest developments in new human-relevant mannequin techniques.

We doc the regulatory and analysis panorama on this subject in India. We additionally talk about the challenges current on this subject which embrace lack of coaching and abilities to deal with embryonic or induced pluripotent stem cell (iPSC) strains, funding limitations, lack of home manufacturing of reagents resulting in elevated prices, and lack of infrastructure, comparable to microfabrication amenities. Ultimately, we offer suggestions to allow innovation and software of human-relevant methodologies to develop India as a key participant on this area globally.

 

Plastic air pollution is without doubt one of the largest environmental issues dealing with the world. Lately, microplastics, polymer particles from 1 µm to five mm, have been getting a lot consideration. The presence of microplastics has already been confirmed in aquatic and marine ecosystems, soil, environment, biota, and others. The natural output from mechanical-biological remedy (MBT) crops was added to the checklist of microplastics sources solely lately. Nevertheless, in keeping with preliminary estimates, it might be the second-largest supply of microplastics.

This text presents an outline of already printed investigations on this microplastics supply and explains the supposed pathway of microplastics within the MBT crops. The principle waste remedy processes that may have an effect on the quantity of microplastics within the natural output have been recognized as shredding, sieving and, to a lesser extent, cardio or anaerobic processing. This mini-review additionally contains strategies used within the scientific literature for microplastics extraction, purification, and identification in organic-rich samples, their benefits and limitations. Specific consideration is paid to the strategies of figuring out the small microplastics, lower than 1 mm, because the strategies for particles 1-5 mm have been extra extensively studied. Moreover, future analysis wants are highlighted.

Comparability of cytotoxicity and smear layer elimination efficacy of triphala (an Indian ayurvedic natural formulation) and 5.25% sodium hypochlorite as root canal irrigants: An in vitro research

Therapeutic potential of crops is an age-old concept that has lately attained renewed curiosity. Contemplating the ineffectiveness, probably dangerous results, and security considerations of generally used artificial irrigants, the natural options for endodontic utilization may show to be advantageous.
The goal of this research was to judge the adequacy of smear layer elimination and cytotoxicity potential of triphala compared to sodium hypochlorite.
The research was performed in two elements: the primary a part of the research was cytotoxicity evaluation studied utilizing Alamar blue assay. L929 mouse fibroblasts have been seeded in 96-well plates at a density of 5000 cells/nicely and handled with completely different concentrations of triphala and NaOCl for a interval of 24 and 48 h. The share of cell viability was then quantified utilizing an Alamar blue assay. The optical density was measured at 570 nm and in contrast with 620 nm, which was thought of as a reference wavelength. The second a part of the research was smear layer evaluation on the coronal, center, and apical third of twenty human premolar enamel utilizing scanning electron microscope.
The Alamar blue reagent cytotoxicity research instructed that triphala confirmed no cytotoxic properties in opposition to the conventional mouse fibroblast cells whereas sodium hypochlorite confirmed a big cytotoxic impact in opposition to the L929 cell strains with the IC50 focus at 1.8%, respectively, after the remedy of 24 h of incubation at 37°C temperature. Triphala was as efficient as sodium hypochlorite in smear layer elimination within the coronal and center third of the basis, however sodium hypochlorite confirmed higher smear layer elimination within the apical third.
Triphala might be thought of as a superior irrigant with good antibacterial efficacy and least cytotoxicity potential in comparison with typical hypochlorite irrigating agent and supply satisfactory clearing of smear layer within the coronal and center third, and additional research are warranted to change the properties of liquid to make it extra cleansable within the apical third of the basis
 The need to develop a framework for human-relevant research in India: Towards better disease models and drug discovery

Peptide-Primarily based Nanomaterials for Tumor Immunotherapy

With the rising understanding of tumor immune circulation mechanisms, tumor immunotherapy together with immune checkpoint blockade has develop into a analysis hotspot, which requires the event of extra correct and extra environment friendly medicine with fewer negative effects.
In step with this requirement, peptides with good biocompatibility, focusing on, and specificity develop into favorable theranostic reagents, and a sequence of promising candidates for tumor immunotherapy based mostly on peptides have been developed. Moreover, the benefits of nanomaterials as drug carriers comparable to larger affinity have been demonstrated, offering prospects of mixture remedy. On this evaluate, we summarize the event of peptide-based nanomaterials in tumor immunotherapy from the 2 elements of functionalization and self-assembly.

Cttnbp2nl ORF Vector (Mouse) (pORF)

ORF042239 1.0 ug DNA
EUR 607.2

Cttnbp2nl ORF Vector (Mouse) (pORF)

ORF042240 1.0 ug DNA
EUR 607.2

CTTNBP2NL Protein Vector (Rat) (pPM-C-HA)

PV262384 500 ng
EUR 723.6

CTTNBP2NL Protein Vector (Rat) (pPB-C-His)

PV262382 500 ng
EUR 723.6

CTTNBP2NL Protein Vector (Rat) (pPB-N-His)

PV262383 500 ng
EUR 723.6

CTTNBP2NL Protein Vector (Rat) (pPM-C-His)

PV262385 500 ng
EUR 723.6

CTTNBP2NL Protein Vector (Mouse) (pPM-C-HA)

PV168952 500 ng
EUR 723.6

CTTNBP2NL Protein Vector (Mouse) (pPM-C-HA)

PV168956 500 ng
EUR 723.6

CTTNBP2NL Protein Vector (Mouse) (pPM-C-HA)

PV168960 500 ng
EUR 723.6

CTTNBP2NL Protein Vector (Human) (pPM-C-HA)

PV011167 500 ng
EUR 394.8

CTTNBP2NL Protein Vector (Mouse) (pPB-C-His)

PV168950 500 ng
EUR 723.6

CTTNBP2NL Protein Vector (Mouse) (pPB-N-His)

PV168951 500 ng
EUR 723.6

CTTNBP2NL Protein Vector (Mouse) (pPM-C-His)

PV168953 500 ng
EUR 723.6

CTTNBP2NL Protein Vector (Mouse) (pPB-C-His)

PV168954 500 ng
EUR 723.6

CTTNBP2NL Protein Vector (Mouse) (pPB-N-His)

PV168955 500 ng
EUR 723.6

CTTNBP2NL Protein Vector (Mouse) (pPM-C-His)

PV168957 500 ng
EUR 723.6

CTTNBP2NL Protein Vector (Mouse) (pPB-C-His)

PV168958 500 ng
EUR 723.6

CTTNBP2NL Protein Vector (Mouse) (pPB-N-His)

PV168959 500 ng
EUR 723.6

CTTNBP2NL Protein Vector (Mouse) (pPM-C-His)

PV168961 500 ng
EUR 723.6

CTTNBP2NL Protein Vector (Human) (pPB-C-His)

PV011165 500 ng
EUR 394.8

CTTNBP2NL Protein Vector (Human) (pPB-N-His)

PV011166 500 ng
EUR 394.8

CTTNBP2NL Protein Vector (Human) (pPM-C-His)

PV011168 500 ng
EUR 394.8

CTTNBP2NL

CSB-CL865207HU 10 μg plasmid + 200μl Glycerol Ask for price

Lenti ORF clone of Cttnbp2nl (mGFP-tagged ORF) - Rat CTTNBP2 N-terminal like (Cttnbp2nl), (10 ug)

RR202426L4 10 µg Ask for price

Lenti ORF particles, CTTNBP2NL (mGFP-tagged) - Human CTTNBP2 N-terminal like (CTTNBP2NL), 200ul, >10^7 TU/mL

RC203727L2V 200 µl Ask for price

Lenti ORF particles, CTTNBP2NL (mGFP-tagged) - Human CTTNBP2 N-terminal like (CTTNBP2NL), 200ul, >10^7 TU/mL

RC203727L4V 200 µl Ask for price

CTTNBP2NL (untagged)-Human CTTNBP2 N-terminal like (CTTNBP2NL)

SC100824 10 µg Ask for price

Lenti ORF particles, Cttnbp2nl (GFP-tagged ORF) - Rat CTTNBP2 N-terminal like (Cttnbp2nl), 200ul, >10^7 TU/mL

RR202426L4V 200 µl Ask for price

Lenti ORF particles, CTTNBP2NL (Myc-DDK tagged) - Human CTTNBP2 N-terminal like (CTTNBP2NL), 200ul, >10^7 TU/mL

RC203727L1V 200 µl Ask for price

Lenti ORF particles, CTTNBP2NL (Myc-DDK tagged) - Human CTTNBP2 N-terminal like (CTTNBP2NL), 200ul, >10^7 TU/mL

RC203727L3V 200 µl Ask for price

Lenti ORF clone of Cttnbp2nl (Myc-DDK-tagged ORF) - Rat CTTNBP2 N-terminal like (Cttnbp2nl), (10 ug)

RR202426L3 10 µg Ask for price

Cttnbp2nl - Rat shRNA lentiviral particles (4 unique 29mer target-specific shRNA, 1 scramble control), 0.5 ml each, >10^7 TU/ml.

TL706262V 500 ul each Ask for price

Cttnbp2nl - Mouse shRNA lentiviral particles (4 unique 29mer target-specific shRNA, 1 scramble control), 0.5 ml each, >10^7 TU/ml.

TL505330V 500 ul each Ask for price

CTTNBP2NL - Human shRNA lentiviral particles (4 unique 29mer target-specific shRNA, 1 scramble control), 0.5 ml each, >10^7 TU/ml.

TL305169V 500 ul each Ask for price

Lenti ORF particles, Cttnbp2nl (Myc-DDK-tagged ORF) - Rat CTTNBP2 N-terminal like (Cttnbp2nl), 200ul, >10^7 TU/mL

RR202426L3V 200 µl Ask for price

Cttnbp2nl (GFP-tagged) - Mouse CTTNBP2 N-terminal like (Cttnbp2nl)

MG209671 10 µg Ask for price

CTTNBP2NL (GFP-tagged) - Human CTTNBP2 N-terminal like (CTTNBP2NL)

RG203727 10 µg Ask for price

Cttnbp2nl sgRNA CRISPR Lentivector set (Rat)

K6403801 3 x 1.0 ug
EUR 406.8

CTTNBP2 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)

LV662881 1.0 ug DNA
EUR 3093.6

CTTNBP2 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC)

LV662885 1.0 ug DNA
EUR 3093.6

CTTNBP2NL, NT (CTTNBP2NL, KIAA1433, CTTNBP2 N-terminal-like protein)

MBS6007388-02mL 0.2(mL
EUR 695

CTTNBP2NL, NT (CTTNBP2NL, KIAA1433, CTTNBP2 N-terminal-like protein)

MBS6007388-5x02mL 5x0.2mL
EUR 2975

Lenti ORF clone of Cttnbp2nl (mGFP-tagged) - Mouse CTTNBP2 N-terminal like (Cttnbp2nl), transcript variant 1

MR217706L4 10 µg Ask for price

Lenti ORF clone of Cttnbp2nl (mGFP-tagged) - Mouse CTTNBP2 N-terminal like (Cttnbp2nl), transcript variant 3

MR216171L4 10 µg Ask for price

Lenti ORF clone of Cttnbp2nl (mGFP-tagged) - Mouse CTTNBP2 N-terminal like (Cttnbp2nl), transcript variant 2

MR209671L4 10 µg Ask for price

CTTNBP2NL sgRNA CRISPR Lentivector set (Human)

K0531401 3 x 1.0 ug
EUR 406.8

Cttnbp2nl sgRNA CRISPR Lentivector set (Mouse)

K4656201 3 x 1.0 ug
EUR 406.8

CTTNBP2 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a)

LV662886 1.0 ug DNA
EUR 3093.6

CTTNBP2NL, NT (CTTNBP2NL, KIAA1433, CTTNBP2 N-terminal-like protein) (AP)

MBS6289979-02mL 0.2mL
EUR 980

CTTNBP2NL, NT (CTTNBP2NL, KIAA1433, CTTNBP2 N-terminal-like protein) (AP)

MBS6289979-5x02mL 5x0.2mL
EUR 4250

CTTNBP2NL, NT (CTTNBP2NL, KIAA1433, CTTNBP2 N-terminal-like protein) (PE)

MBS6289989-02mL 0.2mL
EUR 980

CTTNBP2NL, NT (CTTNBP2NL, KIAA1433, CTTNBP2 N-terminal-like protein) (PE)

MBS6289989-5x02mL 5x0.2mL
EUR 4250

CTTNBP2NL (Myc-DDK-tagged)-Human CTTNBP2 N-terminal like (CTTNBP2NL)

RC203727 10 µg Ask for price

CTTNBP2NL, NT (CTTNBP2NL, KIAA1433, CTTNBP2 N-terminal-like protein) (APC)

MBS6289980-02mL 0.2mL
EUR 980

CTTNBP2NL, NT (CTTNBP2NL, KIAA1433, CTTNBP2 N-terminal-like protein) (APC)

MBS6289980-5x02mL 5x0.2mL
EUR 4250

CTTNBP2NL, NT (CTTNBP2NL, KIAA1433, CTTNBP2 N-terminal-like protein) (FITC)

MBS6289982-02mL 0.2mL
EUR 980

CTTNBP2NL, NT (CTTNBP2NL, KIAA1433, CTTNBP2 N-terminal-like protein) (FITC)

MBS6289982-5x02mL 5x0.2mL
EUR 4250

Lenti ORF clone of Cttnbp2nl (Myc-DDK-tagged) - Mouse CTTNBP2 N-terminal like (Cttnbp2nl), transcript variant 1

MR217706L3 10 µg Ask for price

Lenti ORF clone of Cttnbp2nl (Myc-DDK-tagged) - Mouse CTTNBP2 N-terminal like (Cttnbp2nl), transcript variant 3

MR216171L3 10 µg Ask for price

Lenti ORF clone of Cttnbp2nl (Myc-DDK-tagged) - Mouse CTTNBP2 N-terminal like (Cttnbp2nl), transcript variant 2

MR209671L3 10 µg Ask for price

Cttnbp2nl (untagged ORF) - Rat CTTNBP2 N-terminal like (Cttnbp2nl), (10 ug)

RN202426 10 µg Ask for price

CTTNBP2NL, NT (CTTNBP2NL, KIAA1433, CTTNBP2 N-terminal-like protein) (Biotin)

MBS6289981-02mL 0.2mL
EUR 980

CTTNBP2NL, NT (CTTNBP2NL, KIAA1433, CTTNBP2 N-terminal-like protein) (Biotin)

MBS6289981-5x02mL 5x0.2mL
EUR 4250

Cttnbp2nl sgRNA CRISPR Lentivector (Rat) (Target 1)

K6403802 1.0 ug DNA
EUR 184.8

Cttnbp2nl sgRNA CRISPR Lentivector (Rat) (Target 2)

K6403803 1.0 ug DNA
EUR 184.8

Cttnbp2nl sgRNA CRISPR Lentivector (Rat) (Target 3)

K6403804 1.0 ug DNA
EUR 184.8

CTTNBP2NL, NT (CTTNBP2NL, KIAA1433, CTTNBP2 N-terminal-like protein) (MaxLight 405)

MBS6289984-01mL 0.1mL
EUR 980

CTTNBP2NL, NT (CTTNBP2NL, KIAA1433, CTTNBP2 N-terminal-like protein) (MaxLight 405)

MBS6289984-5x01mL 5x0.1mL
EUR 4250

CTTNBP2NL, NT (CTTNBP2NL, KIAA1433, CTTNBP2 N-terminal-like protein) (MaxLight 490)

MBS6289985-01mL 0.1mL
EUR 980

CTTNBP2NL, NT (CTTNBP2NL, KIAA1433, CTTNBP2 N-terminal-like protein) (MaxLight 490)

MBS6289985-5x01mL 5x0.1mL
EUR 4250

CTTNBP2NL, NT (CTTNBP2NL, KIAA1433, CTTNBP2 N-terminal-like protein) (MaxLight 550)

MBS6289986-01mL 0.1mL
EUR 980

CTTNBP2NL, NT (CTTNBP2NL, KIAA1433, CTTNBP2 N-terminal-like protein) (MaxLight 550)

MBS6289986-5x01mL 5x0.1mL
EUR 4250

CTTNBP2NL, NT (CTTNBP2NL, KIAA1433, CTTNBP2 N-terminal-like protein) (MaxLight 650)

MBS6289987-01mL 0.1mL
EUR 980

CTTNBP2NL, NT (CTTNBP2NL, KIAA1433, CTTNBP2 N-terminal-like protein) (MaxLight 650)

MBS6289987-5x01mL 5x0.1mL
EUR 4250

CTTNBP2NL, NT (CTTNBP2NL, KIAA1433, CTTNBP2 N-terminal-like protein) (MaxLight 750)

MBS6289988-01mL 0.1mL
EUR 980

CTTNBP2NL, NT (CTTNBP2NL, KIAA1433, CTTNBP2 N-terminal-like protein) (MaxLight 750)

MBS6289988-5x01mL 5x0.1mL
EUR 4250

CTTNBP2NL sgRNA CRISPR Lentivector (Human) (Target 1)

K0531402 1.0 ug DNA
EUR 184.8

CTTNBP2NL sgRNA CRISPR Lentivector (Human) (Target 2)

K0531403 1.0 ug DNA
EUR 184.8

CTTNBP2NL sgRNA CRISPR Lentivector (Human) (Target 3)

K0531404 1.0 ug DNA
EUR 184.8

Cttnbp2nl sgRNA CRISPR Lentivector (Mouse) (Target 1)

K4656202 1.0 ug DNA
EUR 184.8

Cttnbp2nl sgRNA CRISPR Lentivector (Mouse) (Target 2)

K4656203 1.0 ug DNA
EUR 184.8

Cttnbp2nl sgRNA CRISPR Lentivector (Mouse) (Target 3)

K4656204 1.0 ug DNA
EUR 184.8

CTTNBP2NL cDNA Clone

MBS1266265-001mgPlasmid02mLGlycerolStock 0.01mgPlasmid+0.2mLGlycerol-Stock
EUR 615

CTTNBP2NL cDNA Clone

MBS1266265-5x001mgPlasmid5x02mLGlycerolStock 5x0.01mgPlasmid+5x0.2mLGlycerol-Stock
EUR 2720

Cttnbp2nl (Myc-DDK-tagged ORF) - Rat CTTNBP2 N-terminal like (Cttnbp2nl), (10 ug)

RR202426 10 µg Ask for price

CTTNBP2NL, NT (CTTNBP2NL, KIAA1433, CTTNBP2 N-terminal-like protein) (Azide free) (HRP)

MBS6289983-02mL 0.2mL
EUR 980

CTTNBP2NL, NT (CTTNBP2NL, KIAA1433, CTTNBP2 N-terminal-like protein) (Azide free) (HRP)

MBS6289983-5x02mL 5x0.2mL
EUR 4250

Lenti ORF particles, Cttnbp2nl (GFP-tagged) - Mouse CTTNBP2 N-terminal like (Cttnbp2nl), transcript variant 1, 200ul, >10^7 TU/mL

MR217706L4V 200 µl Ask for price

Lenti ORF particles, Cttnbp2nl (GFP-tagged) - Mouse CTTNBP2 N-terminal like (Cttnbp2nl), transcript variant 3, 200ul, >10^7 TU/mL

MR216171L4V 200 µl Ask for price

Lenti ORF particles, Cttnbp2nl (GFP-tagged) - Mouse CTTNBP2 N-terminal like (Cttnbp2nl), transcript variant 2, 200ul, >10^7 TU/mL

MR209671L4V 200 µl Ask for price

Mouse CTTNBP2NL siRNA

20-abx913166
  • Ask for price
  • Ask for price
  • 15 nmol
  • 30 nmol

Human CTTNBP2NL siRNA

20-abx913167
  • Ask for price
  • Ask for price
  • 15 nmol
  • 30 nmol

CTTNBP2NL siRNA (Mouse)

MBS8231596-15nmol 15nmol
EUR 405

CTTNBP2NL siRNA (Mouse)

MBS8231596-30nmol 30nmol
EUR 565

CTTNBP2NL siRNA (Mouse)

MBS8231596-5x30nmol 5x30nmol
EUR 2450

CTTNBP2NL siRNA (Human)

MBS8211563-15nmol 15nmol
EUR 405

CTTNBP2NL siRNA (Human)

MBS8211563-30nmol 30nmol
EUR 565

CTTNBP2NL siRNA (Human)

MBS8211563-5x30nmol 5x30nmol
EUR 2450

Lenti ORF particles, Cttnbp2nl (Myc-DDK-tagged) - Mouse CTTNBP2 N-terminal like (Cttnbp2nl), transcript variant 1, 200ul, >10^7 TU/mL

MR217706L3V 200 µl Ask for price

Lenti ORF particles, Cttnbp2nl (Myc-DDK-tagged) - Mouse CTTNBP2 N-terminal like (Cttnbp2nl), transcript variant 3, 200ul, >10^7 TU/mL

MR216171L3V 200 µl Ask for price

Lenti ORF particles, Cttnbp2nl (Myc-DDK-tagged) - Mouse CTTNBP2 N-terminal like (Cttnbp2nl), transcript variant 2, 200ul, >10^7 TU/mL

MR209671L3V 200 µl Ask for price

CTTNBP2 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-C-term-HA)

LV662882 1.0 ug DNA
EUR 3093.6

anti- CTTNBP2NL antibody

FNab02069 100µg
EUR 658.5
Description: Antibody raised against CTTNBP2NL

Cttnbp2nl - Rat, 4 unique 29mer shRNA constructs in retroviral untagged vector

TR706262 5 µg/vial Ask for price

Cttnbp2nl (untagged) - Mouse CTTNBP2 N-terminal like (Cttnbp2nl), transcript variant 1, (10ug)

MC200168 10 µg Ask for price

CTTNBP2 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro)

LV662883 1.0 ug DNA
EUR 3163.2

CTTNBP2 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)

LV662884 1.0 ug DNA
EUR 3163.2

CTTNBP2NL cloning plasmid

CSB-CL865207HU-10ug 10ug
EUR 776.4
Description: A cloning plasmid for the CTTNBP2NL gene.

Cttnbp2nl - Mouse, 4 unique 29mer shRNA constructs in retroviral untagged vector

TR505330 5 µg/vial Ask for price

CTTNBP2NL - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector

TR305169 5 µg/vial Ask for price

Cttnbp2nl (GFP-tagged) - Mouse CTTNBP2 N-terminal like (Cttnbp2nl) transcript variant 1, (10ug)

MG217706 10 µg Ask for price

Cttnbp2nl (GFP-tagged) - Mouse CTTNBP2 N-terminal like (Cttnbp2nl) transcript variant 3, (10ug)

MG216171 10 µg Ask for price

Cttnbp2nl (Myc-DDK-tagged) - Mouse CTTNBP2 N-terminal like (Cttnbp2nl), transcript variant 1

MR217706 10 µg Ask for price

Cttnbp2nl (Myc-DDK-tagged) - Mouse CTTNBP2 N-terminal like (Cttnbp2nl), transcript variant 3

MR216171 10 µg Ask for price

Cttnbp2nl (Myc-DDK-tagged) - Mouse CTTNBP2 N-terminal like (Cttnbp2nl), transcript variant 2

MR209671 10 µg Ask for price

CTTNBP2NL ELISA KIT|Human

EF008912 96 Tests
EUR 826.8

Cttnbp2 - Rat, 4 unique 29mer shRNA constructs in lentiviral GFP vector

TL708241 5 µg/vial Ask for price

CTTNBP2NL (NM_018704) Human Recombinant Protein

E45H40196M5 20 ug
EUR 785.42

Cttnbp2nl (NM_001163332) Mouse Recombinant Protein

E45M45408M5 20 ug
EUR 1924.54

CTTNBP2NL (NM_018704) Human Recombinant Protein

PROTQ9P2B4 20ug
EUR 1249
Description: Recombinant protein of human CTTNBP2 N-terminal like (CTTNBP2NL)

CTTNBP2NL Antibody (N-term)

E45R15642G-1 100 ul
EUR 395

CTTNBP2NL Antibody (N-term)

E45R15642G-4 50 ul
EUR 295

CTTNBP2NL Antibody (N-term)

MBS9209611-008mL 0.08mL
EUR 210

CTTNBP2NL Antibody (N-term)

MBS9209611-04mL 0.4mL
EUR 430

CTTNBP2NL Antibody (N-term)

MBS9209611-5x04mL 5x0.4mL
EUR 1910

Cttnbp2 - Mouse, 4 unique 29mer shRNA constructs in lentiviral GFP vector

TL502777 5 µg/vial Ask for price

CTTNBP2 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector

TL305170 5 µg/vial Ask for price

Cttnbp2nl sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat)

K6403805 3 x 1.0 ug
EUR 451.2

Mouse CTTNBP2NL shRNA Plasmid

20-abx979012
  • Ask for price
  • Ask for price
  • 150 µg
  • 300 µg

Human CTTNBP2NL shRNA Plasmid

20-abx961012
  • Ask for price
  • Ask for price
  • 150 µg
  • 300 µg

Human CTTNBP2NL Protein Lysate

MBS8410104-002mg 0.02mg
EUR 365

Human CTTNBP2NL Protein Lysate

MBS8410104-5x002mg 5x0.02mg
EUR 1410

CTTNBP2NL sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)

K0531405 3 x 1.0 ug
EUR 451.2

Cttnbp2nl sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse)

K4656205 3 x 1.0 ug
EUR 451.2

CTTNBP2NL (N-term) Rabbit pAb

E2618445 100ul
EUR 225
Description: Available in various conjugation types.

CTTNBP2NL (N-Term) Rabbit pAb

MBS8556745-01mL 0.1mL
EUR 305

CTTNBP2NL (N-Term) Rabbit pAb

MBS8556745-01mLAF405L 0.1mL(AF405L)
EUR 565

CTTNBP2NL (N-Term) Rabbit pAb

MBS8556745-01mLAF405S 0.1mL(AF405S)
EUR 565

CTTNBP2NL (N-Term) Rabbit pAb

MBS8556745-01mLAF610 0.1mL(AF610)
EUR 565

CTTNBP2NL (N-Term) Rabbit pAb

MBS8556745-01mLAF635 0.1mL(AF635)
EUR 565

CTTNBP2NL Recombinant Protein (Rat)

RP196784 100 ug Ask for price

Lenti ORF clone of Human CTTNBP2 N-terminal like (CTTNBP2NL), mGFP tagged

RC203727L2 10 µg Ask for price

Lenti ORF clone of Human CTTNBP2 N-terminal like (CTTNBP2NL), mGFP tagged

RC203727L4 10 µg Ask for price

CTTNBP2NL (NM_018704) Human Over-expression Lysate

E45H10858-2 each
EUR 395

CTTNBP2NL (NM_018704) Human Over-expression Lysate

LS055917 100ug
EUR 628
Description: Transient overexpression lysate of CTTNBP2 N-terminal like (CTTNBP2NL)

Cttnbp2nl sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 1)

K6403806 1.0 ug DNA
EUR 200.4

Cttnbp2nl sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 2)

K6403807 1.0 ug DNA
EUR 200.4

Cttnbp2nl sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 3)

K6403808 1.0 ug DNA
EUR 200.4

Mouse Cttnbp2nl qPCR Primer Pair

QM46586S 200 Tests Ask for price

Human CTTNBP2NL qPCR Primer Pair

QH46189S 200 Tests Ask for price

Recombinant Human CTTNBP2NL Protein

E30P66526A 50 ug
EUR 295

CTTNBP2NL Recombinant Protein (Mouse)

RP126710 100 ug Ask for price

CTTNBP2NL Recombinant Protein (Mouse)

RP126713 100 ug Ask for price

CTTNBP2NL Recombinant Protein (Mouse)

RP126716 100 ug Ask for price

CTTNBP2NL Recombinant Protein (Human)

RP008374 100 ug Ask for price

OAGA06361-100UL - CTTNBP2NL Antibody

OAGA06361-100UL 100ul
EUR 369
Moreover, new strategies for peptide screening, particularly machine-learning-related methods, can be a subject we have been interested by, as this types the idea for the development of peptide-based platforms. Peptides present broad prospects for tumor immunotherapy and we hope that this abstract can present perception into potential avenues for future exploration.

Related Posts

Leave a Reply

Your email address will not be published. Required fields are marked *